Cargando…

Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection

Latent Epstein-Barr virus (EBV) infection is causally linked to several human cancers. EBV expresses viral oncogenes that promote cell growth and inhibit the apoptotic response to uncontrolled proliferation. The EBV oncoprotein LMP1 constitutively activates NFκB and is critical for survival of EBV-i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Price, Alexander M, Dai, Joanne, Bazot, Quentin, Patel, Luv, Nikitin, Pavel A, Djavadian, Reza, Winter, Peter S, Salinas, Cristina A, Barry, Ashley Perkins, Wood, Kris C, Johannsen, Eric C, Letai, Anthony, Allday, Martin J, Luftig, Micah A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2017
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425254/ https://www.ncbi.nlm.nih.gov/pubmed/28425914 http://dx.doi.org/10.7554/eLife.22509

Ejemplares similares

Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the STK39 Gene in B Cells Infected by EBV
por: Bazot, Quentin, et al.
Publicado: (2018)

Recent advances in understanding Epstein-Barr virus
por: Stanfield, Brent A., et al.
Publicado: (2017)

Requirement for PRC1 subunit BMI1 in host gene activation by Epstein–Barr virus protein EBNA3C
por: Paschos, Kostas, et al.
Publicado: (2019)

To Be or Not IIb: A Multi-Step Process for Epstein-Barr Virus Latency Establishment and Consequences for B Cell Tumorigenesis
por: Price, Alexander M., et al.
Publicado: (2015)

Core binding factor (CBF) is required for Epstein-Barr virus EBNA3 proteins to regulate target gene expression
por: Paschos, Kostas, et al.
Publicado: (2017)

Epstein-Barr Virus Nuclear Antigen 3C Inhibits Expression of COBLL1 and the ADAM28-ADAMDEC1 Locus via Interaction with the Histone Lysine Demethylase KDM2B
por: Gillman, Adam C. T., et al.
Publicado: (2018)

CAGE-seq analysis of Epstein-Barr virus lytic gene transcription: 3 kinetic classes from 2 mechanisms
por: Djavadian, Reza, et al.
Publicado: (2018)

An Epstein-Barr Virus-Encoded Protein Complex Requires an Origin of Lytic Replication In Cis to Mediate Late Gene Transcription
por: Djavadian, Reza, et al.
Publicado: (2016)

Identification of Host Biomarkers of Epstein-Barr Virus Latency IIb and Latency III
por: Messinger, Joshua E., et al.
Publicado: (2019)

Rta is the principal activator of Epstein-Barr virus epithelial lytic transcription
por: Ali, Ahmed, et al.
Publicado: (2022)

Epstein-Barr Virus Proteins EBNA3A and EBNA3C Together Induce Expression of the Oncogenic MicroRNA Cluster miR-221/miR-222 and Ablate Expression of Its Target p57(KIP2)
por: Bazot, Quentin, et al.
Publicado: (2015)

Epstein-Barr virus induces adhesion molecule CD226 (DNAM-1) expression during primary B cell transformation into lymphoblastoid cell lines
por: Grossman, Lisa V, et al.
Publicado: (2012)

An ATM/Chk2-mediated DNA damage responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells
por: Nikitin, Pavel A., et al.
Publicado: (2010)

Epstein-Barr virus (EBV)-associated miRNAs are important for the maintenance of EBV transformed B cells
por: Linnstaedt, Sarah, et al.
Publicado: (2010)

Epstein-Barr Virus Induces Adhesion Receptor CD226 (DNAM-1) Expression during Primary B-Cell Transformation into Lymphoblastoid Cell Lines
por: Grossman, Lisa, et al.
Publicado: (2017)

Evaluation of plasma Epstein–Barr virus DNA as a biomarker for Epstein–Barr virus–associated Hodgkin lymphoma
por: Usha, Masuma Khatun, et al.
Publicado: (2021)

Epstein-Barr virus perpetuates B cell germinal center dynamics and generation of autoimmune-associated phenotypes in vitro
por: SoRelle, Elliott D., et al.
Publicado: (2022)

Epstein–Barr virus infection is associated with clinical characteristics and poor prognosis of multiple myeloma
por: Xia, Bing, et al.
Publicado: (2019)

How does Epstein–Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?
por: Allday, Martin J.
Publicado: (2009)

Antitumor effects of duvelisib on Epstein–Barr virus‐associated lymphoma cells
por: Kawada, Jun‐ichi, et al.
Publicado: (2018)

An ATM/Chk2-mediated DNA damage responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells
por: Nikitin, Pavel, et al.
Publicado: (2010)

Epstein-Barr virus evades restrictive host chromatin closure by subverting B cell activation and germinal center regulatory loci
por: SoRelle, Elliott D., et al.
Publicado: (2023)

A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection
por: Bristol, Jillian A., et al.
Publicado: (2018)

Estimating the global burden of Epstein–Barr virus-related cancers
por: Wong, Yide, et al.
Publicado: (2021)

Mechanisms of Epstein‐Barr virus nuclear antigen 1 favor Tregs accumulation in nasopharyngeal carcinoma
por: Wang, Jie, et al.
Publicado: (2020)

Latent Epstein-Barr Virus Can Inhibit Apoptosis in B Cells by Blocking the Induction of NOXA Expression
por: Yee, Jade, et al.
Publicado: (2011)

Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein‐Barr virus associated nasopharyngeal carcinoma
por: Liu, Lingzhi, et al.
Publicado: (2019)

An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model
por: Romero-Masters, James C., et al.
Publicado: (2018)

MDM2-dependent inhibition of P53 is required for Epstein-Barr virus B cell growth transformation and infected cell survival
por: Forte, E, et al.
Publicado: (2009)

Limited nucleotide pools restrict Epstein–Barr virus-mediated B-cell immortalization
por: Hafez, A Y, et al.
Publicado: (2017)

Associations between environmental factors and serological Epstein‐Barr virus antibodies in patients with nasopharyngeal carcinoma in South China
por: Zhou, Ting, et al.
Publicado: (2019)

Next‐generation sequencing of miRNAs in clinical samples of Epstein–Barr virus‐associated B‐cell lymphomas
por: Sakamoto, Kouta, et al.
Publicado: (2017)

Role of latent membrane protein 1 in chronic active Epstein–Barr virus infection-derived T/NK-cell proliferation
por: Ito, Takuto, et al.
Publicado: (2014)

Epstein–Barr virus protein EB2 stimulates cytoplasmic mRNA accumulation by counteracting the deleterious effects of SRp20 on viral mRNAs
por: Juillard, Franceline, et al.
Publicado: (2012)

Epstein–Barr virus nuclear antigen (EBNA) 3A induces the expression of and interacts with a subset of chaperones and co-chaperones
por: Young, Paul, et al.
Publicado: (2008)

Assessing the potential association between Epstein-Barr virus and oral squamous cell carcinoma: a systematic review and meta-analysis
por: Sivakumar, Shivaranjhany, et al.
Publicado: (2020)

The B subunit of Escherichia coli enterotoxin helps control the in vivo growth of solid tumors expressing the Epstein–Barr virus latent membrane protein 2A
por: Ondondo, Beatrice, et al.
Publicado: (2015)

Smoking can increase nasopharyngeal carcinoma risk by repeatedly reactivating Epstein‐Barr Virus: An analysis of a prospective study in southern China
por: Hu, Ting, et al.
Publicado: (2019)

Epstein–Barr virus nuclear antigen 3A protein regulates CDKN2B transcription via interaction with MIZ-1
por: Bazot, Quentin, et al.
Publicado: (2014)

EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency
por: Styles, Christine T., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_177kt49sg3fqu8p21i7q5v6qhk